Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

RSPH vs FTXH overlap: 23% of top holdings shared

Bottom line

How much do RSPH and FTXH overlap?

23% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 12.7% of RSPH's assets and 27.1% of FTXH's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

RSPHFTXH
Weight overlap (top 25)23%
Shared holdings7
Weight in shared holdings12.7%27.1%
Total positions6351
Expense ratio0.4%0.6%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings RSPH and FTXH have in common

Holding% of RSPH% of FTXHOverlap
Regeneron Pharmaceuticals, Inc.1.96%2.72%1.96%
Charles River Laboratories International, Inc.1.93%1.49%1.49%
Bristol-Myers Squibb Co.1.82%6.29%1.82%
Amgen Inc.1.77%3.18%1.77%
Incyte Corp.1.76%2.39%1.76%
AbbVie Inc.1.73%7.39%1.73%
Viatris Inc.1.72%3.62%1.72%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in RSPH

  1. Bio-Techne Corp. — 2.13%
  2. IQVIA Holdings Inc. — 2.00%
  3. Baxter International Inc. — 1.99%
  4. Mettler-Toledo International Inc. — 1.94%
  5. Veeva Systems Inc. — 1.93%
  6. DaVita Inc. — 1.87%
  7. Moderna, Inc. — 1.85%
  8. Thermo Fisher Scientific Inc. — 1.84%
  9. Abbott Laboratories — 1.83%
  10. Universal Health Services, Inc. — 1.80%
  11. Labcorp Holdings Inc. — 1.78%
  12. Quest Diagnostics Inc. — 1.77%
  13. Becton, Dickinson and Co. — 1.73%
  14. DexCom, Inc. — 1.73%
  15. Revvity, Inc. — 1.72%

Only in FTXH

  1. Eli Lilly & Company — 7.77%
  2. Merck & Company Inc — 7.07%
  3. Johnson & Johnson — 6.96%
  4. Biogen Inc — 3.84%
  5. Cardinal Health Inc — 3.53%
  6. Vertex Pharmaceuticals Inc — 3.41%
  7. Pfizer Inc — 2.97%
  8. Gilead Sciences Inc — 2.89%
  9. United Therapeutics Corp — 2.72%
  10. Jazz Pharmaceuticals Plc — 2.49%
  11. Illumina Inc — 1.98%
  12. Zoetis Inc — 1.87%
  13. Exelixis Inc — 1.72%
  14. Medpace Holdings Inc — 1.41%
  15. Ptc Therapeutics Inc — 1.37%

Asset mix

Asset typeRSPHFTXH
Stocks99.9%99.9%
Cash & short-term funds2.3%0.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryRSPHFTXH
US98.9%95.6%
IE3.4%3.8%
BM—0.6%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do RSPH and FTXH overlap?
About 23% by weight. 7 securities appear in both funds' top 25 holdings; they make up 12.7% of RSPH's assets and 27.1% of FTXH's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do RSPH and FTXH have in common?
The largest shared holdings are Regeneron Pharmaceuticals, Inc., Bristol-Myers Squibb Co., Amgen Inc., Incyte Corp., AbbVie Inc..
Should I own both RSPH and FTXH?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, RSPH or FTXH?
RSPH is broader, with 63 positions versus 51 for FTXH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.